Virus-like particles as preventive and therapeutic cancer vaccines

AL Tornesello, M Tagliamonte, FM Buonaguro… - Vaccines, 2022 - mdpi.com
Virus-like particles (VLPs) are self-assembled viral protein complexes that mimic the native
virus structure without being infectious. VLPs, similarly to wild type viruses, are able to …

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta …

KS Kechagias, I Kalliala, SJ Bowden, A Athanasiou… - Bmj, 2022 - bmj.com
Objective To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of
HPV infection and recurrent diseases related to HPV infection in individuals undergoing …

Advances on prevention and screening of gynecologic tumors: are we stepping forward?

A Giannini, G Bogani, E Vizza, V Chiantera, AS Laganà… - Healthcare, 2022 - mdpi.com
According to 2020 comprehensive global cancer statistics published by the International
Agency for Research on Cancer, gynecologic malignancies accounted overall for 16.5% of …

Adjuvant HPV vaccination to prevent recurrent cervical dysplasia after surgical treatment: a meta-analysis

V Di Donato, G Caruso, M Petrillo, E Kontopantelis… - Vaccines, 2021 - mdpi.com
Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …

[HTML][HTML] Recurrent or primary metastatic cervical cancer: current and future treatments

C Gennigens, G Jerusalem, L Lapaille, M De Cuypere… - ESMO open, 2022 - Elsevier
Despite screening programs for early detection and the approval of human papillomavirus
vaccines, around 6% of women with cervical cancer (CC) are discovered with primary …

What factors are associated with attitudes towards HPV vaccination among Kazakhstani women? Exploratory analysis of cross-sectional survey data

G Aimagambetova, A Babi, T Issa, A Issanov - Vaccines, 2022 - mdpi.com
Background. The high prevalence of HPV infection among Kazakhstani women and the
absence of an HPV vaccination program are directly reflected in increasing rates of cervical …

[HTML][HTML] Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer

M Reuschenbach, J Doorbar, M Del Pino, EA Joura… - Vaccine, 2023 - Elsevier
Individuals with human papillomavirus (HPV)-related disease remain at risk for subsequent
HPV infection and related disease after treatment of specific lesions. Prophylactic HPV …

Updates on cervical cancer prevention

D Viveros-Carreño, A Fernandes… - International Journal of …, 2023 - ijgc.bmj.com
In 2020, approximately 604 127 patients were newly diagnosed with cervical cancer and
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …

HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM

KCM Gosens, RP Van Der Zee, MLS Van Heukelom… - Aids, 2021 - journals.lww.com
Objective: Anal cancer precursor lesions high-grade anal intraepithelial neoplasia (HGAIN)
are highly prevalent among HIV+ MSM. Treatment of HGAIN is frustrated by high recurrence …

A study on the correlation between the prognosis of HPV infection and lesion recurrence after cervical conization

J Lu, S Han, Y Li, J Na, J Wang - Frontiers in Microbiology, 2023 - frontiersin.org
Introduction Persistent human papillomavirus infection is an important factor in the
development of cervical cancer, which is usually a long process evolving from the …